ArticleCancer immunology, immunotherapy : CII2024

Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer.

Angisha Basnet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.